Holocene Advisors’s Amgen AMGN Stock Holding History

Holocene Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-192,200	Closed	-$48.9M	–	730
2020 Q3	$48.9M	Buy	+192,200	New	+$47.6M	0.37%	90

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Holocene Advisors's AMGN Position: Q1 2026 in Review

Holocene Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 158,000 shares — an estimated $51.7M sold.

Holocene Advisors first reported a position in AMGN in Q4 2017 and held it in 3 quarters. The position peaked at $59.2M in Q4 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Holocene Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Holocene Advisors sold 158,000 Amgen shares in Q1 2026, an estimated $51.7M.
Holocene Advisors first reported a position in Amgen in Q4 2017 and held it in 3 quarters.
Holocene Advisors's Amgen position peaked at $59.2M in Q4 2024.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.